💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Central Banks And More Earnings

Published 02/02/2023, 15:36
Updated 02/02/2023, 16:41
Central Banks And More Earnings
IXIC
-

Benzinga - Good Morning Everyone!

Especially Mark Zuckerberg who stopped hanging out in the metaverse. Cut costs and returned to cash flow positive. Stock up 20% pre-market set to gain $200 billion.

Next catalyst, AI?

Prices as of 4 pm EST, 2/1/23; % YTD

MARKET UPDATE

The U.S. Federal Reserve delivered an expected 25 basis point hike

  • Signals a “couple” more hikes before a pause

ECB

  • Delivers 50 basis point hike

  • Signals more hikes ahead

Bank of England

  • Raised by 50 basis points to 4%

  • 10th consecutive increase

  • Like the Fed, close to a pause

Crude 76 -0.5%

Meta (NASDAQ: META) +19%

  • Q4 revenue 32.2 billion at high end of guide $30-32.5

  • Ad revenues up 2% y/y

  • Q1 revenue guide $26-$28.5 Billion vs $27B consensus

  • 2023 operating expenses comes down to $89-95B from $94-100B

  • After repurchasing $7 billion of stock in Q4, buyback increased by $40 billion

  • How big is $40 billion. It’s 10% of the market cap.

  • Don’t bet against Zuck

  • Solid revenue, Solid guide, larger than expected capex cut, big share buyback

  • Chart: Average Revenue per user (ARPU)

  • People are using Meta products. Ad impressions up 23% y/y. Reels is having an impact.

Auto

  • U.S. January SAAR 16.2 million units vs. street 15.3

  • Incentives down 22.9% at $1,400 per car

  • Days supply is 37 vs. 33 last month

Earnings

  • MetLife (NYSE: MET) flat EPS $1.55 vs street $1.65

  • McKesson (NYSE: MCK) -2% raised 2023 EPS guide

  • Alfac (NYSE: AFL) flat EPS $1.29 vs street $1.21

  • Corteva (NYSE: CTVA) -2% guide lower than street

  • Allstate (NYSE: ALL) flat Auto loss ratio worse than street

  • Align (NASDAQ: ALGN) +17% revenues down but better than street, $1 cash reserves

  • Eli Lilly (NYSE: LLY) -2% top line miss, bottom line beat

  • Merck (NYSE: MRK) -1% EPS $6.90 beat street $6.35, raised guide

  • Shell (NYSE: SHEL) +2% record profits of $42.3 billion, increased dividend and share buyback

  • Bristol-Myers (NYSE: BMY) +1% Q4 revenues +2%, earnings +5%, 2% increase to guide

  • ConocoPhillips (NYSE: COP) -1% 4% cash flow beat, capex modestly higher

  • Honeywell (NASDAQ: HON) -3% EPS in line, guide light

  • Sony (NYSE: SONY) +2% in-line, boosts guide

  • Estee Lauder (NYSE: EL) -3% guide is light

  • Ferrari (NYSE: RACE) +5% revenue and EBITDA beat

Tonight

  • Apple (NASDAQ: AAPL)

  • Google (NASDAQ: GOOGL)

  • Amazon (NASDAQ: AMZN)

  • Starbucks (NASDAQ: SBUX)

CRYPTO UPDATE 99-year old Charlie Munger on crypto

  • “Instead, it’s a gambling contract with a nearly 100% edge for the house, entered into in a country where gambling contracts are traditionally regulated only by states that compete in laxity”

  • “The U.S. should now enact a new federal law that prevents this from happening”

Alameda Research

  • Alameda wallet received over $10 million in crypto overnight

  • $6 million in tether from Bitfinex

  • $4.5 million in USDC from unknown entity

  • Reasons unclear

Risk appetite

  • More than half of altcoins outperforming Bitcoin (CRYPTO: BTC) over last 30 days

  • Suggest higher risk appetite

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.